Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models

G L Rosner1, P Müller

  • 1Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

Journal of Pharmacokinetics and Biopharmaceutics
|April 1, 1997
PubMed
Summary

This study introduces a novel population modeling approach using weighted normal distributions. It enables flexible estimation of drug variability and covariate effects for safer patient dosing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nitroprusside improves tumor perfusion during local 42°C hyperthermia.

Veterinary anaesthesia and analgesia·2017
Same author

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.

The pharmacogenomics journal·2015
Same author

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer.

Prostate cancer and prostatic diseases·2013
Same author

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy.

Blood cancer journal·2013
Same author

Pharmacogenetic pathway analysis of irinotecan.

Clinical pharmacology and therapeutics·2008
Same author

PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.

Pharmacological reviews·2004

Area of Science:

  • Pharmacometrics and Pharmacodynamics
  • Statistical Modeling
  • Drug Development

Background:

  • Population studies are crucial for understanding drug variability in disposition and effects.
  • This knowledge is essential for optimizing safe and effective patient dosing.
  • Current methods may require prespecified distributional forms, limiting flexibility.

Purpose of the Study:

  • To present a new, flexible approach to population modeling.
  • To estimate continuous population distributions without assuming their parametric form.
  • To enable nonparametric regression of pharmacokinetic/pharmacodynamic parameters on covariates.

Main Methods:

  • Utilizes a weighted mixture of normal distributions with random weights and means.
  • Allows for estimation of underlying population distributions nonparametrically.

Related Experiment Videos

  • Integrates covariate analysis within the distribution estimation framework.

    • Main Results:

    • The proposed method effectively estimates population distributions without prespecification.
    • Demonstrates flexibility in handling complex pharmacokinetic/pharmacodynamic data.
    • Successfully performs nonparametric regression of parameters on covariates.

    Conclusions:

    • The new weighted mixture model offers a powerful and flexible tool for population pharmacokinetic/pharmacodynamic analysis.
    • This approach enhances the ability to characterize drug variability and covariate influences.
    • Facilitates more precise and individualized dosing strategies for future patients.